Home Categories API Famotidine
A4364612

Famotidine , ≥99% , 76824-35-6

Synonym(s):
{3-[((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio]-N′-(aminosulfonyl)propaneimidamide};N′-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine;Famotidine

CAS NO.:76824-35-6

Empirical Formula: C8H15N7O2S3

Molecular Weight: 337.45

MDL number: MFCD00079297

EINECS: 616-396-9

Pack Size Price Stock Quantity
5G RMB447.20 In Stock
25G RMB1199.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 163-164°C
Boiling point: 562.7±60.0 °C(Predicted)
Density  1.5111 (rough estimate)
refractive index  1.7400 (estimate)
storage temp.  2-8°C
solubility  Very slightly soluble in water, freely soluble in glacial acetic acid, very slightly soluble in anhydrous ethanol, practically insoluble in ethyl acetate. It dissolves in dilute mineral acids
pka pKa 6.76(H2O t=23.0) (Uncertain)
form  Solid
color  White to Off-White
Water Solubility  1.1 mg/mL
BCS Class 3
Stability: Light Sensitive
InChI InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
InChIKey XUFQPHANEAPEMJ-UHFFFAOYSA-N
SMILES C(NS(N)(=O)=O)(=N)CCSCC1=CSC(NC(N)=N)=N1

Description and Uses

Famotidine is a competitive histamine H2-receptor antagonist, and the main pharmacodynamic effect of famotidine is to cause the inhibition of gastric secretion. Famotidine on decomposition releases toxic products such as carbon oxides (CO, CO2), nitrogen oxides (NO, NO2), and sulphur oxides (SO2, SO3). Famotidine is a medication that is available both in prescription and over-the-counter forms. It is used to treat conditions related to the oesophagus, stomach, and intestines. Some specific famotidine is used for the treatment of duodenal ulcers, gastric ulcers (stomach ulcers), gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions that occur when stomach acid is secreted/ produced in very large quantities, an abnormal health condition called ‘Zollinger-Ellison syndrome’.

For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H303
Precautionary statements  P270-P301+P312-P403-P501c
Hazard Codes  T
Risk Statements  20/21/22-45-61
Safety Statements  22-24/25-53-45-36/37/39
WGK Germany  2
RTECS  UA2300000
HS Code  29341000
Toxicity LD50 i.v. in mice: 244.4 mg/kg (Yasufumi)

RELATED PRODUCTS